Beijing Tiantan Biological Products Co., Ltd. (SHA:600161)
China flag China · Delayed Price · Currency is CNY
14.19
-0.07 (-0.49%)
May 6, 2026, 3:00 PM CST

SHA:600161 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,8921,9912,6864,5553,7134,330
Cash & Short-Term Investments
1,8921,9912,6864,5553,7134,330
Cash Growth
-17.06%-25.86%-41.04%22.68%-14.25%147.68%
Accounts Receivable
2,2662,2021,12194.131,1731,027
Other Receivables
9.767.613.4539.0828.3622.27
Receivables
2,2762,2091,134133.211,2011,050
Inventory
4,1484,0223,8692,8442,3322,144
Other Current Assets
37.9949.5833.436.5324.8722.27
Total Current Assets
8,3538,2727,7227,5697,2717,546
Property, Plant & Equipment
5,9055,9065,8484,8864,0552,631
Long-Term Investments
141.05143.2143.2146.06146.06146.06
Goodwill
572.15572.15572.15173.92173.92127.93
Other Intangible Assets
862.98880.47917.05686.88441.63370.99
Long-Term Deferred Tax Assets
57.5956.4341.7746.7460.6367.01
Long-Term Deferred Charges
675.19655.09507.82470.26552.69362.46
Other Long-Term Assets
108.4797.76117.66208.66228.88326.85
Total Assets
16,67516,58315,87014,18812,92911,578
Accounts Payable
92.8981.3681.45179.169.3973.7
Accrued Expenses
89.56153.87170.46168.69163.21150.02
Short-Term Debt
4.577.12----
Current Portion of Long-Term Debt
16.36---112.99108.15
Current Portion of Leases
-15.698.9617.9510.8216.51
Current Income Taxes Payable
167.3179.51148.2161.8573.7944.86
Current Unearned Revenue
172.91177.89213.19357.26292.72215.31
Other Current Liabilities
403.76449.21498.07494.78434.44201.03
Total Current Liabilities
947.31,0351,1201,2801,157809.58
Long-Term Debt
----253.75366.25
Long-Term Leases
70.9468.0144.8624.4225.6218.01
Long-Term Unearned Revenue
96.8398.66107.4499.56101.992.69
Long-Term Deferred Tax Liabilities
62.1564.2262.4428.8530.8720.14
Other Long-Term Liabilities
1.241.241.241.244.14.1
Total Liabilities
1,1781,2671,3361,4341,5741,311
Common Stock
1,9771,9771,9771,6481,6481,373
Additional Paid-In Capital
2,4632,4632,4632,7932,7933,067
Retained Earnings
7,4227,2956,6985,3824,3553,612
Comprehensive Income & Other
-0.1-0.1-0.1-0.1-0.1-0.1
Total Common Equity
11,86311,73511,1399,8238,7958,052
Minority Interest
3,6343,5813,3942,9322,5602,215
Shareholders' Equity
15,49715,31614,53312,75411,35610,267
Total Liabilities & Equity
16,67516,58315,87014,18812,92911,578
Total Debt
91.8160.8253.8242.37403.17508.92
Net Cash (Debt)
1,8001,8302,6324,5133,3103,821
Net Cash Growth
-16.34%-30.46%-41.68%36.34%-13.38%303.40%
Net Cash Per Share
0.900.921.332.281.661.97
Filing Date Shares Outstanding
2,0981,9771,9771,9771,9771,977
Total Common Shares Outstanding
2,0981,9771,9771,9771,9771,977
Working Capital
7,4067,2386,6026,2906,1136,736
Book Value Per Share
5.655.935.634.974.454.07
Tangible Book Value
10,42810,2839,6508,9628,1807,553
Tangible Book Value Per Share
4.975.204.884.534.143.82
Buildings
-2,9632,7112,2411,957963.02
Machinery
-3,1222,7602,2181,9961,258
Construction In Progress
-2,1772,4782,0441,5321,623
Source: S&P Global Market Intelligence. Standard template. Financial Sources.